Circulating MicroRNAs in Understanding Pathogenesis of Systemic Lupus Erythematosis
NCT02756546
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Systemic Lupus Erythematosis
Interventions
DRUG:
Cyclophosphamide
DRUG:
Hydroxychloroquine
DRUG:
Hydrocortisone
Sponsor
Cairo University